| 1 |
Wang D, Guan S, Lu P, Li Y, Xu H. Extracellular vesicles: Critical bilateral communicators in periphery-brain crosstalk in central nervous system disorders. Biomed Pharmacother 2023;160:114354. [PMID: 36753954 DOI: 10.1016/j.biopha.2023.114354] [Reference Citation Analysis]
|
| 2 |
Singh J, Boettcher M, Dölling M, Heuer A, Hohberger B, Leppkes M, Naschberger E, Schapher M, Schauer C, Schoen J, Stürzl M, Vitkov L, Wang H, Zlatar L, Schett GA, Pisetsky DS, Liu ML, Herrmann M, Knopf J. Moonlighting chromatin: when DNA escapes nuclear control. Cell Death Differ 2023;:1-15. [PMID: 36755071 DOI: 10.1038/s41418-023-01124-1] [Reference Citation Analysis]
|
| 3 |
Wadowski PP, Panzer B, Józkowicz A, Kopp CW, Gremmel T, Panzer S, Koppensteiner R. Microvascular Thrombosis as a Critical Factor in Severe COVID-19. Int J Mol Sci 2023;24. [PMID: 36768817 DOI: 10.3390/ijms24032492] [Reference Citation Analysis]
|
| 4 |
Tuculeanu G, Barbu EC, Lazar M, Chitu-Tisu CE, Moisa E, Negoita SI, Ion DA. Coagulation Disorders in Sepsis and COVID-19-Two Sides of the Same Coin? A Review of Inflammation-Coagulation Crosstalk in Bacterial Sepsis and COVID-19. J Clin Med 2023;12. [PMID: 36675530 DOI: 10.3390/jcm12020601] [Reference Citation Analysis]
|
| 5 |
Kalbhenn J, Pooth JS, Trummer G, Kranzhöfer D, Schlagenhauf A, Zieger B. Pervasive Platelet Secretion Defects in Patients with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Cells 2023;12. [PMID: 36611985 DOI: 10.3390/cells12010193] [Reference Citation Analysis]
|
| 6 |
Dean LS, Devendra G, Jiyarom B, Subia N, Tallquist MD, Nerurkar VR, Chang SP, Chow DC, Shikuma CM, Park J. Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequalae of SARS-CoV-2 infection. Front Immunol 2022;13:1076724. [PMID: 36591237 DOI: 10.3389/fimmu.2022.1076724] [Reference Citation Analysis]
|
| 7 |
Revenstorff J, Ludwig N, Hilger A, Mersmann S, Lehmann M, Grenzheuser JC, Kardell M, Bone J, Kötting NM, Marx NC, Roth J, Vogl T, Rossaint J. Role of S100A8/A9 in Platelet-Neutrophil Complex Formation during Acute Inflammation. Cells 2022;11. [PMID: 36497202 DOI: 10.3390/cells11233944] [Reference Citation Analysis]
|
| 8 |
Urano T, Yasumoto A, Yokoyama K, Horiuchi H, Morishita E, Suzuki Y. COVID-19 and Thrombosis: Clinical Aspects. Curr Drug Targets 2022;23:1567-72. [PMID: 36200150 DOI: 10.2174/1389450123666221005092350] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Muradov AM, Ibragimova AA, Nazirova NZ, Valieva US, Shumilina MV. Features of the hemostasis system in COVID-19. jour 2022. [DOI: 10.52888/0514-2515-2022-354-3-102-108] [Reference Citation Analysis]
|
| 10 |
Borczuk AC, Yantiss RK. The pathogenesis of coronavirus-19 disease. J Biomed Sci 2022;29:87. [PMID: 36289507 DOI: 10.1186/s12929-022-00872-5] [Reference Citation Analysis]
|
| 11 |
Garishah FM, Huskens D, Pramudo SG, Andriani D, Astrilia M, Sentosa RA, van der Ven AJAM, Laat B, Gasem MH, de Mast Q, Roest M. Hyperresponsive Platelets and a Reduced Platelet Granule Release Capacity Are Associated with Severity and Mortality in COVID-19 Patients. Thromb Haemost 2022. [PMID: 36220126 DOI: 10.1055/s-0042-1757163] [Reference Citation Analysis]
|
| 12 |
Rai R. Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases. Purinergic System 2022. [DOI: 10.5772/intechopen.104978] [Reference Citation Analysis]
|
| 13 |
Shen H. Purinergic Signaling in Covid-19 Disease. Purinergic System 2022. [DOI: 10.5772/intechopen.105008] [Reference Citation Analysis]
|
| 14 |
Falcinelli E, Petito E, Gresele P. The role of platelets, neutrophils and endothelium in COVID-19 infection. Expert Rev Hematol 2022. [PMID: 35930267 DOI: 10.1080/17474086.2022.2110061] [Reference Citation Analysis]
|
| 15 |
Conway EM, Pryzdial ELG. Complement contributions to COVID-19. Curr Opin Hematol 2022. [PMID: 35852851 DOI: 10.1097/MOH.0000000000000724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Ferrari D, Rubini M, Burns JS. The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2. Front Immunol 2022;13:904419. [DOI: 10.3389/fimmu.2022.904419] [Reference Citation Analysis]
|
| 17 |
Ludwig N, Hilger A, Zarbock A, Rossaint J. Platelets at the Crossroads of Pro-Inflammatory and Resolution Pathways during Inflammation. Cells 2022;11:1957. [PMID: 35741086 DOI: 10.3390/cells11121957] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 18 |
Andrade SAD, de Souza DA, Torres AL, de Lima CFG, Ebram MC, Celano RMG, Schattner M, Chudzinski-tavassi AM. Pathophysiology of COVID-19: Critical Role of Hemostasis. Front Cell Infect Microbiol 2022;12:896972. [DOI: 10.3389/fcimb.2022.896972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Goubran H, Seghatchian J, Sabry W, Ragab G, Burnouf T. Platelet and extracellular vesicles in COVID-19 infection and its vaccines. Transfusion and Apheresis Science 2022. [DOI: 10.1016/j.transci.2022.103459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 20 |
Mandel J, Casari M, Stepanyan M, Martyanov A, Deppermann C. Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation. Int J Mol Sci 2022;23:3868. [PMID: 35409226 DOI: 10.3390/ijms23073868] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 21 |
Uzun G, Pelzl L, Singh A, Bakchoul T. Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia. Front Immunol 2022;13:837629. [PMID: 35273612 DOI: 10.3389/fimmu.2022.837629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 22 |
Rondina MT. Editorial: special review series on viruses and platelets. Platelets 2022;33:174-5. [PMID: 34937498 DOI: 10.1080/09537104.2021.2020491] [Reference Citation Analysis]
|
| 23 |
Ostroumova O, Polyakova O, Kochetkov A. The use of acetylsalicylic acid for prevention of cardiovascular complications in patients undergoing COVID-19. A review of current recommendations. Kardiol serdechno-sosud khir 2022;15:656. [DOI: 10.17116/kardio202215061656] [Reference Citation Analysis]
|
| 24 |
Conway EM, Mackman N, Warren RQ, Wolberg AS, Mosnier LO, Campbell RA, Gralinski LE, Rondina MT, van de Veerdonk FL, Hoffmeister KM, Griffin JH, Nugent D, Moon K, Morrissey JH. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 2022;22:639-49. [PMID: 35931818 DOI: 10.1038/s41577-022-00762-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 20.0] [Reference Citation Analysis]
|
